STOCKWATCH
·
Pharmaceuticals
New Launch17 Feb 2026, 10:23 am

Zydus Lifesciences Launches PEPAIR™, India's First Affordable OPEP Device for Respiratory Health

AI Summary

Zydus Lifesciences Limited, an innovation-led life-sciences company, has launched PEPAIR™, India's first affordable Oscillating Positive Expiratory Pressure (OPEP) device. This handheld device, featuring a 3-resistance system, is designed to help clear congestion and support effective mucous clearance and improve breathing in patients with COPD, Asthma, and Bronchiectasis. PEPAIR™ is being launched in agreement with AeroDel Technology Innovations Pvt. Ltd at an affordable cost of Rs. 990 per unit. Zydus, one of India’s largest respiratory players, aims to address the access gap in OPEP-based airway clearance therapy, which is recommended in established clinical guidance but has been limited by affordability.

Key Highlights

  • Zydus Lifesciences launches PEPAIR™, India's first affordable OPEP device for respiratory health.
  • PEPAIR™ is designed to help clear congestion and support effective mucous clearance in patients with COPD, Asthma, and Bronchiectasis.
  • PEPAIR™ is an innovative, drug-free, handheld device with a patented design.
  • Zydus aims to address the access gap in OPEP-based airway clearance therapy.
  • PEPAIR™ is launched in agreement with AeroDel Technology Innovations Pvt. Ltd at an affordable cost.
ZYDUSLIFE
Pharmaceuticals
Zydus Lifesciences Ltd

Price Impact